U.S. Treasury yields are inching higher after Monday’s drop, as investors navigate the holiday-shortened trading week. But ...

Piper Sandler's Christopher Raymond joins 'Fast Money' to talk Amgen's stock sinking on GLP-1 results. Kamala Harris ...

In a report released today, Thomas Champion from Piper Sandler maintained a Buy rating on Amazon (AMZN – Research Report), with a price target ...

We recently published a list of 15 Trending AI Stocks on Latest News and Ratings. In this article, we are going to take a ...

Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize universal-RAS/RAF medicines for broad populations of cancer patients, today announced ...

Piper Sandler has downgraded Danimer Scientific (DNMR) to underweight, citing mounting financial problems. Read more here.

On Tuesday, Replimune Group Inc (REPL) stock saw a modest uptick, ending the day at $14.38 which represents a slight increase of $1.12 or 8.45% from the prior close of $13.26. The stock opened at $13.

Piper Sandler analyst Brent Bracelin raised the firm’s price target on Procore (PCOR) to $90 from $70 and keeps an Overweight ...

Piper Sandler raised the firm’s price target on CyberArk (CYBR) to $345 from $300 and keeps an Overweight rating on the ...

today announced that management will participate in a fireside chat at the Piper Sandler 36 th Annual Healthcare Conference on Thursday, December 5, 2024, at 9:00 AM Eastern Time. A live audio webcast ...

Inozyme Pharma is a pioneering clinical-stage biopharmaceutical company dedicated to developing innovative therapeutics for rare diseases that affect bone health and blood vessel function. We are ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...